Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Quarterly results
Consulting agrmnt
Director departure
Appointed director
|
|
NEPHROS INC (NEPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/08/2022 |
8-K
| Appointed a new director |
| 05/02/2019 |
8-K
| Appointed a new director |
| 02/13/2019 |
8-K
| Appointed a new director |
| 08/13/2018 |
8-K
| Appointed a new director |
| 11/20/2007 |
8-K
| Appointed a new director |
| 09/25/2007 |
8-K
| Appointed a new director|
Docs:
|
"Form of Amendment to the Fourth Amended and Restated Certificate of Incorporation for Nephros, Inc",
"Form of Series A 10% Secured Convertible Note due 2008 convertible into Common Stock and Warrants",
"Form of Series B 10% Secured Convertible Note due 2008 convertible into Common Stock",
"Form of Class D Warrant",
"Form of Placement Agent Warrant",
"Form of Subscription Agreement between Nephros and each New Investor",
"Exchange Agreement, between Nephros and the Exchange Investors",
"Registration Rights Agreement, among Nephros and the Investors",
"Investor Rights Agreement, among Nephros and the Investors",
"Placement Agent Agreement, among Nephros, NSC and Dinosaur",
"Separation Agreement and Release, between Nephros and William J. Fox",
"Nephros Raises $12.7 Million in New Financing" |
|
| 09/21/2006 |
8-K
| Appointed a new director |
| 04/25/2005 |
8-K
| Appointed a new director |
|
|